These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22455591)

  • 21. Lipid-Drug Conjugate for Enhancing Drug Delivery.
    Irby D; Du C; Li F
    Mol Pharm; 2017 May; 14(5):1325-1338. PubMed ID: 28080053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral bioavailability of curcumin: problems and advancements.
    Liu W; Zhai Y; Heng X; Che FY; Chen W; Sun D; Zhai G
    J Drug Target; 2016 Sep; 24(8):694-702. PubMed ID: 26942997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silica encapsulated lipid-based drug delivery systems for reducing the fed/fasted variations of ziprasidone in vitro.
    Dening TJ; Rao S; Thomas N; Prestidge CA
    Eur J Pharm Biopharm; 2016 Apr; 101():33-42. PubMed ID: 26812284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluations.
    Erdal MS; Özhan G; Mat MC; Özsoy Y; Güngör S
    Int J Nanomedicine; 2016; 11():1027-37. PubMed ID: 27042058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic Evaluation of Improved Oral Bioavailability of Valsartan: Proliposomes Versus Self-Nanoemulsifying Drug Delivery System.
    Nekkanti V; Wang Z; Betageri GV
    AAPS PharmSciTech; 2016 Aug; 17(4):851-62. PubMed ID: 26381913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug carriers for the delivery of therapeutic peptides.
    Du AW; Stenzel MH
    Biomacromolecules; 2014 Apr; 15(4):1097-114. PubMed ID: 24661025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microemulsions as a surrogate carrier for dermal drug delivery.
    Azeem A; Khan ZI; Aqil M; Ahmad FJ; Khar RK; Talegaonkar S
    Drug Dev Ind Pharm; 2009 May; 35(5):525-47. PubMed ID: 19016057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzyl Benzoate-Loaded Microemulsion for Topical Applications: Enhanced Dermatokinetic Profile and Better Delivery Promises.
    Sharma G; Dhankar G; Thakur K; Raza K; Katare OP
    AAPS PharmSciTech; 2016 Oct; 17(5):1221-31. PubMed ID: 26669889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo evaluations of the performance of an indirubin derivative, formulated in four different self-emulsifying drug delivery systems.
    Heshmati N; Cheng X; Dapat E; Sassene P; Eisenbrand G; Fricker G; Müllertz A
    J Pharm Pharmacol; 2014 Nov; 66(11):1567-75. PubMed ID: 24961657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential of Liposomes for Enhancement of Oral Drug Absorption.
    Daeihamed M; Dadashzadeh S; Haeri A; Akhlaghi MF
    Curr Drug Deliv; 2017; 14(2):289-303. PubMed ID: 26768542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incomplete desorption of liquid excipients reduces the in vitro and in vivo performance of self-emulsifying drug delivery systems solidified by adsorption onto an inorganic mesoporous carrier.
    Van Speybroeck M; Williams HD; Nguyen TH; Anby MU; Porter CJ; Augustijns P
    Mol Pharm; 2012 Sep; 9(9):2750-60. PubMed ID: 22870936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentials of human bile acids and their salts in pharmaceutical nano delivery and formulations adjuvants.
    Kecman S; Škrbić R; Badnjevic Cengic A; Mooranian A; Al-Salami H; Mikov M; Golocorbin-Kon S
    Technol Health Care; 2020; 28(3):325-335. PubMed ID: 31594273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-in-cyclodextrin-in-liposomes: a promising delivery system for hydrophobic drugs.
    Chen J; Lu WL; Gu W; Lu SS; Chen ZP; Cai BC; Yang XX
    Expert Opin Drug Deliv; 2014 Apr; 11(4):565-77. PubMed ID: 24490763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.
    Ahsan F; Rivas IP; Khan MA; Torres Suarez AI
    J Control Release; 2002 Feb; 79(1-3):29-40. PubMed ID: 11853916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.
    Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N
    Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PEG-lipid micelles as drug carriers: physiochemical attributes, formulation principles and biological implication.
    Gill KK; Kaddoumi A; Nazzal S
    J Drug Target; 2015 Apr; 23(3):222-31. PubMed ID: 25547369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Theory and practice of supersaturatable formulations for poorly soluble drugs.
    Kawakami K
    Ther Deliv; 2015 Mar; 6(3):339-52. PubMed ID: 25853309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fabrication of supramolecular star-shaped amphiphilic copolymers for ROS-triggered drug release.
    Zuo C; Peng J; Cong Y; Dai X; Zhang X; Zhao S; Zhang X; Ma L; Wang B; Wei H
    J Colloid Interface Sci; 2018 Mar; 514():122-131. PubMed ID: 29248814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and optimization of self-nanoemulsifying drug delivery systems for improved bioavailability of cyclovirobuxine D.
    Ke Z; Hou X; Jia XB
    Drug Des Devel Ther; 2016; 10():2049-60. PubMed ID: 27418807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.